{"nct_id":"NCT02100618","title":"Antibody Persistence for GlaxoSmithKline (GSK) Biologicals' HPV-16/18 L1 VLP AS04 Vaccine (GSK-580299) Administered in Healthy Adults and Adolescents, 6.5 Years After First Vaccination in the Primary Study","status":"WITHDRAWN","status_verified_date":"2015-07","start_date":"2015-01","start_date_type":null,"primary_completion_date":"2015-04","primary_completion_date_type":"ESTIMATED","completion_date":"2015-04","completion_date_type":"ESTIMATED","phases":["PHASE3"],"tickers":["GSK"]}